NEOGENNSENeogen Chemicals LimitedHighNeutral
Announced Sat, 18 Apr · 13:53 IST

Neogen Chemicals Limited has informed the Exchange regarding allotment of 10,00,000 equity shares pursuant to Preferential Issue at its Fund Raising Committee meeting held on April 18, 2026

Fund Raising View source PDF

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹1512.90
prior close
₹1501.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.9+0.8-1.7-0.0+9.7+9.1+8.4+9.3+10.0+8.4+11.2+26.6+43.4
Up moveDown movePending
AI summary

Neogen Chemicals has allotted 10 lakh equity shares to Cadamba Solutions Private Limited, a promoter group entity, at Rs. 1,610 per share (including Rs. 1,600 premium per share). The total fundraising amounts to Rs. 161 crore. The issue price is 17.02% above the SEBI-mandated floor price of Rs. 1,375.82, determined as per ICDR regulations. Post-allotment, Cadamba Solutions holds 3.65% of the company's expanded equity capital, which increased from Rs. 26.38 crore to Rs. 27.38 crore. The shares carry a lock-in period of 18 months as per SEBI ICDR regulations for promoter group allotments.

Likely market impact

The preferential allotment to a promoter group entity strengthens the promoter stake by 3.65% without bringing in external institutional capital. The 17% premium to floor price indicates promoter confidence in the company's valuation. Existing shareholders will see minor dilution as share count increases by approximately 3.8%.